Shattuck Labs is a biotechnology company. Its platform Agonist Redirected Checkpoint is used to build therapeutic medicines for oncology and inflammatory diseases. The therapy is based on consolidating checkpoint blockade and TNF (tumor necrosis factor) receptor agonists into single therapeutics.